Fin Trust Capital Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Fin Trust Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$51.49 - $81.64 $38,977 - $61,801	-757 Reduced 32.66%	1,561 $91,000
Q1 2022 May 03, 2022	BUY	$60.03 - $76.49 $115,557 - $147,243	1,925 Added 489.82%	2,318 $176,000
Q3 2021 Nov 16, 2021	SELL	$54.64 - $61.3 $27,320 - $30,650	-500 Reduced 55.99%	393 $22,000
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $189,376 - $223,967	-3,200 Reduced 78.18%	893 $54,000
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $212,211 - $282,017	3,578 Added 694.76%	4,093 $287,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $8,075 - $10,601	-160 Reduced 23.7%	515 $31,000
Q3 2020 Nov 10, 2020	SELL	$51.97 - $63.0 $42,199 - $51,156	-812 Reduced 54.61%	675 $41,000
Q2 2020 Sep 11, 2020	BUY	$30.8 - $52.47 $45,799 - $78,022	1,487 New	1,487 $78,000
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $22,638 - $38,565	-735 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$35.66 - $44.99 $4,421 - $5,578	124 Added 20.29%	735 $28,000
Q1 2019 May 09, 2019	BUY	$36.47 - $42.17 $22,283 - $25,765	611 New	611 $23,000

258

49.4M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.